94 (10.51%), respectively, but the difference was borderline non-significant (OR 1.62, 95%CI 0.97–2.71).
← all excerpts
The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement.
1
—
—
94 (10.51%), respectively, but the difference was borderline non-significant (OR 1.62, 95%CI 0.97–2.71).